High-Dose Therapy and Autologous Blood Stem Cell Transplantation (ASCT) Followed by Post-Transplant Immunotherapy With Costimulated Autologous T-Cells in Conjunction With Pneumococcal Conjugate Vaccine Immunization for Patients With Multiple Myeloma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carmustine; Cyclophosphamide; Melphalan; Multiple myeloma vaccine; Pneumococcal vaccine conjugate
- Indications Multiple myeloma
- Focus Therapeutic Use
- 04 Nov 2019 Biomarkers information updated
- 29 Sep 2009 Planned end date (Feb 2008) added as reported by ClinicalTrials.gov.
- 29 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.